To investigate whether Ferrostatin-1, an ferroptosis inhibitor, affects cell death after ferroptosis activation, si-HULC was used to observe the viability of HCC cells treated with si-HULC in the presence of Ferrostatin-1. This evidence concerns the gene HULC and hepatocellular carcinoma.